Dextromethorphan-Quinidine in Treatment-Resistant Depression: An Open-Label Pilot Study

被引:0
作者
Wang, Philip [1 ]
Yavi, Mani [1 ]
Park, Lawrence [1 ]
Zarate, Carlos [1 ]
机构
[1] NIMH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Clinical Trials; NMDA antagonists; Treatment Resistant Depression; Psychopharmacological Treatment; Dextromethorphan;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
208
引用
收藏
页码:S177 / S178
页数:2
相关论文
共 50 条
  • [41] Defining treatment-resistant depression
    Gaynes, Bradley N.
    Lux, Linda
    Gartlehner, Gerald
    Asher, Gary
    Forman-Hoffman, Valerie
    Green, Josh
    Boland, Erin
    Weber, Rachel P.
    Randolph, Charli
    Bann, Carla
    Coker-Schwimmer, Emmanuel
    Viswanathan, Meera
    Lohr, Kathleen N.
    [J]. DEPRESSION AND ANXIETY, 2020, 37 (02) : 134 - 145
  • [42] Treatment-resistant depression - an update
    Kaschka, WP
    Jandl, M
    [J]. NERVENHEILKUNDE, 2005, 24 (04) : 317 - +
  • [43] Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression: Findings From a Double-Blind Randomized Controlled Trial and Open-Label Extension Phase
    Kennedy, Sidney
    Giacobbe, Peter
    Rizvi, Sakina
    Ceniti, Amanda
    Styra, Rima
    Lozano, Andres
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 250 - 250
  • [44] Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
    Smith-Apeldoorn, Sanne Y.
    Veraart, Jolien K. E.
    Ruhe, Henricus G.
    Rot, Marije Ann Het
    Kamphuis, Jeanine
    de Boer, Marrit K.
    Schoevers, Robert A.
    [J]. BJPSYCH OPEN, 2021, 8 (01):
  • [45] Quetiapine augmentation in treatment-resistant depression: a naturalistic study
    Marina Šagud
    Alma Mihaljević-Peleš
    Dorotea Mück-Šeler
    Miro Jakovljević
    Nela Pivac
    [J]. Psychopharmacology, 2006, 187 : 511 - 514
  • [46] Quetiapine augmentation in treatment-resistant depression:: a naturalistic study
    Sagud, Marina
    Mihaljevic-Peles, Alma
    Muck-Seler, Dorotea
    Jakovljevic, Miro
    Pivac, Nela
    [J]. PSYCHOPHARMACOLOGY, 2006, 187 (04) : 511 - 514
  • [47] Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders - A Randomized, Open-Label Pilot-Study
    Koeck, Patrick
    Lang, Elisabeth
    Trulley, Valerie-Noelle
    Dechent, Frieder
    Mercer-Chalmers-Bender, Katja
    Frei, Priska
    Huber, Christian
    Borgwardt, Stefan
    [J]. FRONTIERS IN PSYCHIATRY, 2021, 12
  • [48] Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study
    Schirman, Shella
    Kronenberg, Sefi
    Apter, Alan
    Brent, David
    Melhem, Nadine
    Pick, Nimrod
    Carmel, Miri
    Frisch, Amos
    Weizman, Abraham
    Gothelf, Doron
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (01) : 139 - 145
  • [49] Lipidomic Signatures Informs Intravenous Racemic Ketamine Associated Remission in Treatment-Resistant Depression: A Pilot Study
    Singh, Balwinder
    MahmoudianDehkordi, Siamak
    Vande Voort, Jennifer
    Han, Xianlin
    Port, John
    Frye, Mark
    Daouk, Rima Kaddurah
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 192 - 192
  • [50] Cognitive correlates of repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant depression- a pilot study
    Karina K Kedzior
    Vikram Rajput
    Greg Price
    Joseph Lee
    Mathew Martin-Iverson
    [J]. BMC Psychiatry, 12